Edwin DeJesus

19.4k citations
150 papers · 10.3k · 5 hit papers · h-index 55

Impact in

  • Virology top 0.05%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 113
    • HIV/AIDS Research and Interventions 28
    • HIV Research and Treatment 52

Edwin DeJesus

147 papers receiving 9.8k citations

Edwin DeJesus's Hit Papers

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection 2022 · 180 citations
1800+6+13Years since publication200400600

Peers

Edwin DeJesus
Comparison fields: 5 of 115
  • Virology 4.2k
  • Infectious Diseases 7.3k
  • Emergency Medicine 1.6k
  • Hepatology 763
  • Epidemiology 1.5k
Replace Donna M. Jacobsen with:
Donna M. Jacobsen United States
Patrick Yéni France
David A. Cooper Australia
Graeme Moyle United Kingdom
José M. Gatell Spain
P. Richard Harrigan Canada
Kathleen Squires United States
Schlomo Staszewski Germany
Gilles Peytavin France
Keith Henry United States
Edwin DeJesus relative to Donna M. Jacobsen United States Donna M. Jacobsen's profile →
Citations per field
00.5×1.5×1.9×
Donna M. Jacobsen · 1×
Citations per year

Countries citing papers authored by Edwin DeJesus

Since Specialization
Citations

This map shows the geographic impact of Edwin DeJesus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin DeJesus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin DeJesus more than expected).

Fields of papers citing papers by Edwin DeJesus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin DeJesus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin DeJesus. The network helps show where Edwin DeJesus may publish in the future.

Co-authors

The 25 scholars most cited alongside Edwin DeJesus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edwin DeJesus Line = papers co-authored together Edwin DeJesus links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Hit paper breakdown →
2006724
2
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Hit paper breakdown →
2008591
3
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Hit paper breakdown →
2009496
4 2012361
5 2008294
6
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Hit paper breakdown →
2017292
7 2012277
8 2006272
9 2013255
10 2006235
11 2005211
12 2004203
13 2010196
14 2008191
15 2006188
16 2004185
17
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
Hit paper breakdown →
2022180
18 2011177
19 2013174
20 2006169

About Edwin DeJesus

Edwin DeJesus is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Hepatology, having authored 150 papers that have together received 10.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (113 papers), HIV Research and Treatment (52 papers), HIV/AIDS Research and Interventions (28 papers), HIV-related health complications and treatments (18 papers), Hepatitis C virus research (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Virology (4.2k citations), Infectious Diseases (7.3k citations), Emergency Medicine (1.6k citations), Hepatology (763 citations) and Epidemiology (1.5k citations). Edwin DeJesus has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Andrew Cheng, Joel E. Gallant, Anton Pozniak, Damian J. McColl, Jeffrey Enejosa, José Ramón Arribas, Peter Ruane, Adriano Lazzarin, John J. Toole and Kirsten White. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Clinical Trials, AIDS, Open Forum Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact